天康生物(002100.SZ)拟12.75亿元取得羌都畜牧控股权 形成优势互补

Core Viewpoint - TianKang Biological plans to acquire 51% stake in Xinjiang Qiangdu Animal Husbandry Technology Co., Ltd. for cash consideration of 1.275 billion yuan, which will make Qiangdu a subsidiary of TianKang [1] Group 1: Acquisition Details - The acquisition will enhance TianKang's overall strength and competitiveness by leveraging the complementary advantages of both companies [1] - Qiangdu specializes in pig farming and sales, with a focus on commodity pigs, piglets, and breeding pigs [1] - Qiangdu employs an integrated pig farming model of "self-breeding and self-raising," creating a complete pig industry chain [1] Group 2: Future Projections - Qiangdu is expected to produce approximately 1.36 million pigs in 2024, with projections exceeding 1.5 million pigs in 2025 [1] Group 3: Strategic Benefits - Post-acquisition, TianKang will integrate its feed technology and animal health systems into Qiangdu, enhancing feed production capacity and vaccine usage [1] - The collaboration aims to achieve a synergistic upgrade in the "feed-animal health-farming" chain [1]